The Antigen of Bordetella pertussis that Induces Bactericidal Antibody and its Relationship to Protection of Mice

References

1. Ayme G., Mynard M. C., Donikian R., Triau R. 1970; Attempts to prepare a non-cellular pertussis vaccine. Symposia Series in lmmunobiological Standardization 13:254–264
   [Google Scholar]
2. Berenbaum M. C., Ungar J., Stevens W. K. 1960; Intracranial infection of mice with Bordetella pertussis . Journal of General Microbiology 22:313–322
   [Google Scholar]
3. Čižnár I., Shands J. W. Jun 1970; Effect of alkali on the immunological reactivity of lipopolysaccha-ride from Salmonella typhimurium . Infection and Immunity 2:549–555
   [Google Scholar]
4. Cohen S. M., Wheeler M. W. 1946; Pertussis vaccine prepared with phase-I cultures grown in fluid medium. American Journal of Public Health 36:371–376
   [Google Scholar]
5. Davies D. A. L. 1956; A specific polysaccharide of Pasteurella pest is . Biochemical Journal 63:105–116
   [Google Scholar]
6. Dolby J. M. 1965; The antibacterial effect of Bordetella pertussis antisera. Immunology 8:484–498
   [Google Scholar]
7. Dolby J. M., Dolby D. E. 1969; The antibody activities of 19 S and 7 S fractions from rabbit antisera to Bordetella pertussis . Immunology 16:737–747
   [Google Scholar]
8. Dolby J. M., Standfast A. F. B. 1961; The intracerebral infection of mice with Bordetella pertussis . Journal of Hygiene 59:205–216
   [Google Scholar]
9. Dolby J. M., Vincent W. A. 1965; Characterization of the antibodies responsible for the ‘bactericidal activity patterns’ of antisera to Bordetella pertussis . Immunology 8:499–510
   [Google Scholar]
10. Farthing J. R., Holt L. B. 1962; Experiments designed to determine the mechanism of the adjuvant activity of Gram-negative organisms upon antibody production. Journal of Hygiene 60:411–426
    [Google Scholar]
11. Finger H., Beneke G., Fresenius H. 1970; Cellular kinetics of 19 S and 7 S hemolysin production in mice under the influence of bacterial endotoxins. Pathologia et Microbiologia 35:324–337
    [Google Scholar]
12. Finger H., Emmerling P., Bruss E. 1970; Variable adjuvant activity of Bordetella pertussis with respect to the primary and secondary immunization of mice. Infection and Immunity 1:251–258
    [Google Scholar]
13. Glynn A. A., Ward M. E. 1970; Nature and heterogeneity of the antigens of Neisseria gonorrhoeaeinvolved in the serum bactericidal reaction. Infection and Immunity 2:162–168
    [Google Scholar]
14. Holt L. B., Spasojevic V., Dolby J. M., Standfast A. F. B. 1961; Immunity in mice to an intracerebral challenge of Bordetella pertussis . Journal of Hygiene 59:373–378
    [Google Scholar]
15. Iida T., Kusano N., Yamamoto A., Konosu M. 1966; An immunofluorescence study of the action of antibody in experimental intracerebral infection of mice with Bordetellapertussis . Journal of Pathology and Bacteriology 92:359–367
    [Google Scholar]
16. Leslie P. H., Gardner A. D. 1931; The phases of Haemophilus pertussis . Journal of Hygiene 31:423–434
    [Google Scholar]
17. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. 1951; Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193:265–275
    [Google Scholar]
18. MacLennan A. P. 1960; Specific lipopolysaccharides of Bordetella . Biochemical Journal 74:398–409
    [Google Scholar]
19. Medicarl Research Council 1956; Vaccination against whooping cough. Relation between protection tests in children and results of laboratory tests. British Medical Journal 2454–462
    [Google Scholar]
20. Miles A. A., Misra S. S. 1938; The estimation of the bactericidal power of the blood. Journal of Hygiene 38:732–749
    [Google Scholar]
21. Morgan W. T. J. 1943; An artificial antigen with blood group A specificity. British Journal of Experimental Pathology 24:41–49
    [Google Scholar]
22. Nakase Y., Tateisi M., Sekiya K., Kasuga T. 1970; Chemical and biological properties of the purified O antigen of Bordetella pertussis . Japanese Journal of Microbiology 14:1–8
    [Google Scholar]
23. Neter E. 1969; Endotoxins and the immune response. Current Topics in Microbiology and Immunology 47:82–124
    [Google Scholar]
24. Pieroni R. E., Levine L. 1970; Use of actinomycin D for quantitation of endotoxin in pertussis vaccine and extracts. Symposia Series in Immunobiological Standardization 13:198–202
    [Google Scholar]
25. Pillemer L. 1950; Adsorption of protective antigen of Haemophilus pertussis on human red cell stromata. Proceedings of the Society for Experimental Biology and Medicine 75:704–705
    [Google Scholar]
26. Pillemer L., Blum L., Lepow I. H. 1954; Protective antigen of Haemophilus pertussis . Lancet i:1257–1260
    [Google Scholar]
27. Pusztai Z., CsizéR Z., Joó I. 1971; The role and specificity of Bordetella lipopolysaccharide in immune reactions. Zeitschrift für Immunitatsforschung 141:129–141
    [Google Scholar]
28. Pusztai Z., Joó I. 1967; Influence of nicotinic acid on the antigenic structure of Bordetella pertussis . Annales Immunologiae Hungaricae 10:63–67
    [Google Scholar]
29. Reed L. J., Muench H. 1938; A simple method of estimating fifty per cent endpoints. American Journal of Hygiene 27:493–497
    [Google Scholar]
30. Sato Y. 1970; Isolation and some properties of the protective antigen from Bordetella pertussis . Symposia Series in Immunobiological Standardization 13:214–220
    [Google Scholar]
31. Staub A. M. 1964; The role of the polysaccharide moiety in determining the specificity and immunological activity of the O-antigen complex of Salmonellae. In Bacterial Endotoxins pp 38–48 Landy M., Braun W. Edited by New Brunswick, New Jersey: Rutgers University Press;
    [Google Scholar]
32. Staub A. M. 1967; Preparation of cell wall antigens from Gram-negative bacteria. Methods in Immunology and Immunochemistry 1:28–34
    [Google Scholar]
33. Wardlaw A. C. 1966; Purified pertussis immunogen: a progress report. Symposia Series in Immunobiological Standardization 3:99–118
    [Google Scholar]